179 related articles for article (PubMed ID: 35668995)
21. Single-Cell RNA-Seq Identifies Pathways and Genes Contributing to the Hyperandrogenemia Associated with Polycystic Ovary Syndrome.
Harris RA; McAllister JM; Strauss JF
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445796
[TBL] [Abstract][Full Text] [Related]
22. AMH inhibits androgen production in human theca cells.
Chen M; Guo X; Zhong Y; Liu Y; Cai B; Wu R; Huang C; Zhou C
J Steroid Biochem Mol Biol; 2023 Feb; 226():106216. PubMed ID: 36356855
[TBL] [Abstract][Full Text] [Related]
23. Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects.
Wood JR; Nelson-Degrave VL; Jansen E; McAllister JM; Mosselman S; Strauss JF
Physiol Genomics; 2005 Feb; 20(3):233-43. PubMed ID: 15598877
[TBL] [Abstract][Full Text] [Related]
24. Cellular and Animal Studies: Insights into Pathophysiology and Therapy of PCOS.
Indran IR; Lee BH; Yong EL
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():12-24. PubMed ID: 27118251
[TBL] [Abstract][Full Text] [Related]
25. Family-Based Quantitative Trait Meta-Analysis Implicates Rare Noncoding Variants in DENND1A in Polycystic Ovary Syndrome.
Dapas M; Sisk R; Legro RS; Urbanek M; Dunaif A; Hayes MG
J Clin Endocrinol Metab; 2019 Sep; 104(9):3835-3850. PubMed ID: 31038695
[TBL] [Abstract][Full Text] [Related]
26. The Search for the Causes of Common Hyperandrogenism, 1965 to circa 2015.
Rosenfield RL
Endocr Rev; 2024 Mar; ():. PubMed ID: 38457123
[TBL] [Abstract][Full Text] [Related]
27. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries.
Gilling-Smith C; Willis DS; Beard RW; Franks S
J Clin Endocrinol Metab; 1994 Oct; 79(4):1158-65. PubMed ID: 7962289
[TBL] [Abstract][Full Text] [Related]
28. DENND1A desensitizes granulosa cells to FSH by arresting intracellular FSHR transportation.
Dou Y; Zhao R; Wu H; Yu Z; Yin C; Yang J; Yang C; Luan X; Cheng Y; Huang T; Bian Y; Han S; Zhang Y; Xu X; Chen ZJ; Zhao H; Zhao S
Sci China Life Sci; 2024 Apr; ():. PubMed ID: 38709439
[TBL] [Abstract][Full Text] [Related]
29. DENND1A gene variants in Bahraini Arab women with polycystic ovary syndrome.
Gammoh E; Arekat MR; Saldhana FL; Madan S; Ebrahim BH; Almawi WY
Gene; 2015 Apr; 560(1):30-3. PubMed ID: 25626177
[TBL] [Abstract][Full Text] [Related]
30. Differential association of DENND1A genetic variants with polycystic ovary syndrome in Tunisian but not Bahraini Arab women.
Dallel M; Sarray S; Douma Z; Hachani F; Al-Ansari AK; Letaifa DB; Mahjoub T; Almawi WY
Gene; 2018 Mar; 647():79-84. PubMed ID: 29325736
[TBL] [Abstract][Full Text] [Related]
31. Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome.
Wachs DS; Coffler MS; Malcom PJ; Shimasaki S; Chang RJ
J Clin Endocrinol Metab; 2008 May; 93(5):1827-33. PubMed ID: 18285408
[TBL] [Abstract][Full Text] [Related]
32. miR-130b-3p is high-expressed in polycystic ovarian syndrome and promotes granulosa cell proliferation by targeting SMAD4.
Bao D; Li M; Zhou D; Zhuang C; Ge Z; Wei Q; Zhang L
J Steroid Biochem Mol Biol; 2021 May; 209():105844. PubMed ID: 33582305
[TBL] [Abstract][Full Text] [Related]
33. Derailed peripheral circadian genes in polycystic ovary syndrome patients alters peripheral conversion of androgens synthesis.
Johnson BS; Krishna MB; Padmanabhan RA; Pillai SM; Jayakrishnan K; Laloraya M
Hum Reprod; 2022 Jul; 37(8):1835-1855. PubMed ID: 35728080
[TBL] [Abstract][Full Text] [Related]
34. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome.
Nelson VL; Qin KN; Rosenfield RL; Wood JR; Penning TM; Legro RS; Strauss JF; McAllister JM
J Clin Endocrinol Metab; 2001 Dec; 86(12):5925-33. PubMed ID: 11739466
[TBL] [Abstract][Full Text] [Related]
35. Targeted deletion of NR2F2 and VCAM1 in theca cells impacts ovarian follicular development: insights into polycystic ovary syndrome?†.
Candelaria NR; Richards JS
Biol Reprod; 2024 Apr; 110(4):782-797. PubMed ID: 38224314
[TBL] [Abstract][Full Text] [Related]
36. Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells.
Wickenheisser JK; Quinn PG; Nelson VL; Legro RS; Strauss JF; McAllister JM
J Clin Endocrinol Metab; 2000 Jun; 85(6):2304-11. PubMed ID: 10852468
[TBL] [Abstract][Full Text] [Related]
37. Luteinizing hormone-induced Akt phosphorylation and androgen production are modulated by MAP Kinase in bovine theca cells.
Fukuda S; Orisaka M; Tajima K; Hattori K; Kotsuji F
J Ovarian Res; 2009 Nov; 2(1):17. PubMed ID: 19917087
[TBL] [Abstract][Full Text] [Related]
38. Regulation of human (adrenal) androgen biosynthesis-New insights from novel throughput technology studies.
Udhane SS; Flück CE
Biochem Pharmacol; 2016 Feb; 102():20-33. PubMed ID: 26498719
[TBL] [Abstract][Full Text] [Related]
39. Luteinizing hormone stimulates the expression of amphiregulin in human theca cells.
Liu Y; Zhong Y; Shen X; Guo X; Wu R; Yang T; Chen M
J Ovarian Res; 2022 Dec; 15(1):129. PubMed ID: 36476625
[TBL] [Abstract][Full Text] [Related]
40. The mechanism for protein kinase C inhibition of androgen production and 17alpha-hydroxylase expression in a theca cell tumor model.
Beshay VE; Havelock JC; Sirianni R; Ye P; Suzuki T; Rainey WE; Carr BR
J Clin Endocrinol Metab; 2007 Dec; 92(12):4802-9. PubMed ID: 17895316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
